Pharmacokinetics of Intravitreal Bevacizumab (Avastin)
Top Cited Papers
- 1 May 2007
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 114 (5), 855-859
- https://doi.org/10.1016/j.ophtha.2007.01.017
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness
This publication has 20 references indexed in Scilit:
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic RetinopathyOphthalmology, 2006
- Absence of Histologic Retinal Toxicity of Intravitreal Bevacizumab in a Rabbit ModelAmerican Journal of Ophthalmology, 2006
- Rapid regression of disc neovascularization in a patient with proliferative diabetic retinopathy following adjunctive intravitreal bevacizumabEye, 2006
- SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- EVALUATION OF IN VITRO EFFECTS OF BEVACIZUMAB (AVASTIN) ON RETINAL PIGMENT EPITHELIAL, NEUROSENSORY RETINAL, AND MICROVASCULAR ENDOTHELIAL CELLSRetina, 2006
- SIX-MONTH STABILITY OF BEVACIZUMAB (AVASTIN) BINDING TO VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER WITHDRAWAL INTO A SYRINGE AND REFRIGERATION OR FREEZINGRetina, 2006
- Clearance of Intravitreal MoxifloxacinInvestigative Opthalmology & Visual Science, 2006
- Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal AdministrationInvestigative Opthalmology & Visual Science, 2005
- Modeling the Route of Administration-Based Enhancement in the Brain Delivery of EAB 515, Studied by MicrodialysisJournal of Drug Targeting, 1997
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979